The rapid rise of SARS‐CoV‐2 Omicron subvariants with immune evasion properties: XBB. 1.5 and BQ. 1.1 subvariants
D Ao, X He, W Hong, X Wei - MedComm, 2023 - Wiley Online Library
As the fifth variant of concern of the SARS‐CoV‐2 virus, the Omicron variant (B. 1.1. 529)
has quickly become the dominant type among the previous circulating variants worldwide …
has quickly become the dominant type among the previous circulating variants worldwide …
The immune response to SARS-CoV-2 in people with HIV
MA Höft, WA Burgers, C Riou - Cellular & Molecular Immunology, 2024 - nature.com
This review examines the intersection of the HIV and SARS-CoV-2 pandemics. People with
HIV (PWH) are a heterogeneous group that differ in their degree of immune suppression …
HIV (PWH) are a heterogeneous group that differ in their degree of immune suppression …
ACE2 binding and antibody evasion in enhanced transmissibility of XBB. 1.5
C Yue, W Song, L Wang, F Jian, X Chen… - The Lancet Infectious …, 2023 - thelancet.com
SARS-CoV-2 subvariants BQ. 1.1 and XBB. 1 have been circulating globally with superior
growth advantages over most omicron mutants (appendix p 5). However, XBB. 1.5, a …
growth advantages over most omicron mutants (appendix p 5). However, XBB. 1.5, a …
Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ. 1.1 variant
In late 2022, various Omicron subvariants emerged and cocirculated worldwide. These
variants convergently acquired amino acid substitutions at critical residues in the spike …
variants convergently acquired amino acid substitutions at critical residues in the spike …
Virological characteristics of the SARS-CoV-2 omicron XBB. 1.16 variant
D Yamasoba, K Uriu, A Plianchaisuk… - The Lancet Infectious …, 2023 - thelancet.com
In late February, 2023, some sublineages of the SARS-CoV-2 omicron XBB variant
harbouring the F486P substitution in the spike protein (eg, XBB. 1.5 and XBB. 1.9) …
harbouring the F486P substitution in the spike protein (eg, XBB. 1.5 and XBB. 1.9) …
Transmissibility, infectivity, and immune evasion of the SARS-CoV-2 BA. 2.86 variant
K Uriu, J Ito, Y Kosugi, YL Tanaka, Y Mugita… - The Lancet Infectious …, 2023 - thelancet.com
In September, 2023, the SARS-CoV-2 XBB descendants, such as XBB. 1.5 and EG. 5.1
(originally XBB. 1.9. 2.5. 1), are the predominant variants circulating worldwide. 1 …
(originally XBB. 1.9. 2.5. 1), are the predominant variants circulating worldwide. 1 …
Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB. 1.5 variant
K Uriu, J Ito, J Zahradnik, S Fujita, Y Kosugi… - The Lancet infectious …, 2023 - thelancet.com
Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron
XBB.1.5 variant - The Lancet Infectious Diseases Skip to Main Content Advertisement The …
XBB.1.5 variant - The Lancet Infectious Diseases Skip to Main Content Advertisement The …
[HTML][HTML] Virological characteristics of the SARS-CoV-2 BA. 2.86 variant
In late 2023, several SARS-CoV-2 XBB descendants, notably EG. 5.1, were predominant
worldwide. However, a distinct SARS-CoV-2 lineage, the BA. 2.86 variant, also emerged …
worldwide. However, a distinct SARS-CoV-2 lineage, the BA. 2.86 variant, also emerged …
Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants
AK Reuschl, LG Thorne, MVX Whelan… - Nature …, 2024 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) human adaptation resulted
in distinct lineages with enhanced transmissibility called variants of concern (VOCs) …
in distinct lineages with enhanced transmissibility called variants of concern (VOCs) …
Virological characteristics of the SARS-CoV-2 Omicron XBB. 1.5 variant
T Tamura, T Irie, S Deguchi, H Yajima, M Tsuda… - Nature …, 2024 - nature.com
Abstract Circulation of SARS-CoV-2 Omicron XBB has resulted in the emergence of XBB.
1.5, a new Variant of Interest. Our phylogenetic analysis suggests that XBB. 1.5 evolved from …
1.5, a new Variant of Interest. Our phylogenetic analysis suggests that XBB. 1.5 evolved from …